Home LiteratureArticle Details
PMID: 7051933 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Ultrastructural alterations of mycobacterium leprae in skin biopsies of untreated and treated lepromatous patients.

Annales de microbiologie ·Vol. 133 ·No. 1 ·1982-00-00 ·Pages 75-92

Silva MT, Macedo PM, Costa MH, Gonçalves H, Torgal J, David HL

Abstract

1. -- Mycobacterium leprae cells under a process of progressive disaggregation are present in the skin of both treated and untreated patients. 2. -- The ultrastructural alterations observed during the degenerative process seem to be qualitatively similar in treated and untreated patients. 3. -- The proportion of altered M. leprae cells increases during the treatment, mainly with rifampicin and rifampicin + clofazimine + diaminodiphenyl sulfone. 4. -- The cell wall of M. leprae is the last bacterial structure to disappear during the degenerative process.

MeSH Terms
Cell Membrane/ultrastructure Cell Wall/ultrastructure Clofazimine/therapeutic use Dapsone/therapeutic use Humans Leprosy/drug therapy,microbiology Microscopy, Electron Mycobacterium leprae/ultrastructure Organoids/ultrastructure Ribosomes/ultrastructure Rifampin/therapeutic use Skin/microbiology
Chemicals
Dapsone Clofazimine Rifampin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Silva M T
Macedo P M
Costa M H
Gonçalves H
Torgal J
David H L
Article Info
Journal
Annales de microbiologie
Abbr.
Ann Microbiol (Paris)
ISSN
0300-5410
Published
1982-00-00
Pages
75-92
Language
English
Region
France
NLM ID
0354704
Subset
IM
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]